229 related articles for article (PubMed ID: 22709525)
1. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.
Martínez-Calatrava MJ; Prieto-Potín I; Roman-Blas JA; Tardio L; Largo R; Herrero-Beaumont G
Arthritis Res Ther; 2012 Jun; 14(3):R149. PubMed ID: 22709525
[TBL] [Abstract][Full Text] [Related]
2. Total glucosides of paeony prevents juxta-articular bone loss in experimental arthritis.
Wei CC; You FT; Mei LY; Jian S; Qiang CY
BMC Complement Altern Med; 2013 Jul; 13():186. PubMed ID: 23870279
[TBL] [Abstract][Full Text] [Related]
3. RANKL expression in chondrocytes and its promotion by lymphotoxin-α in the course of cartilage destruction during rheumatoid arthritis.
Takeshita A; Nishida K; Yoshida A; Nasu Y; Nakahara R; Kaneda D; Ohashi H; Ozaki T
PLoS One; 2021; 16(7):e0254268. PubMed ID: 34234380
[TBL] [Abstract][Full Text] [Related]
4. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
Komuro H; Olee T; Kühn K; Quach J; Brinson DC; Shikhman A; Valbracht J; Creighton-Achermann L; Lotz M
Arthritis Rheum; 2001 Dec; 44(12):2768-76. PubMed ID: 11762937
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.
Kato G; Shimizu Y; Arai Y; Suzuki N; Sugamori Y; Maeda M; Takahashi M; Tamura Y; Wakabayashi N; Murali R; Ono T; Ohya K; Mise-Omata S; Aoki K
Arthritis Res Ther; 2015 Sep; 17(1):251. PubMed ID: 26373710
[TBL] [Abstract][Full Text] [Related]
6. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
[TBL] [Abstract][Full Text] [Related]
7. In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells.
Byron CR; Barger AM; Stewart AA; Pondenis HC; Fan TM
Am J Vet Res; 2010 Jun; 71(6):615-22. PubMed ID: 20513175
[TBL] [Abstract][Full Text] [Related]
8. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.
Moreno-Rubio J; Herrero-Beaumont G; Tardio L; Alvarez-Soria MA; Largo R
Arthritis Rheum; 2010 Feb; 62(2):478-88. PubMed ID: 20112374
[TBL] [Abstract][Full Text] [Related]
10. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits.
Lv Y; Xia JY; Chen JY; Zhao H; Yan HC; Yang HS; Li Q; Fan YX; Guo KJ; Chen XY
BMC Musculoskelet Disord; 2014 Nov; 15():370. PubMed ID: 25377946
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
[TBL] [Abstract][Full Text] [Related]
12. Aminothiazoles inhibit osteoclastogenesis and PGE
Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study on the regulation of subchondral bone plate osteoprotegerin/receptor activator of nuclear factor kappa-B ligand system by berberine to retard the development of osteoarthritis in rabbits].
Zhang JF; Huang K; Cai HL; Zhang PL; Wang J
Zhongguo Gu Shang; 2022 May; 35(5):464-9. PubMed ID: 35535536
[TBL] [Abstract][Full Text] [Related]
14. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y
Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491
[TBL] [Abstract][Full Text] [Related]
15. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
[TBL] [Abstract][Full Text] [Related]
16. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
[TBL] [Abstract][Full Text] [Related]
17. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
[TBL] [Abstract][Full Text] [Related]
18. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
Lubberts E; van den Bersselaar L; Oppers-Walgreen B; Schwarzenberger P; Coenen-de Roo CJ; Kolls JK; Joosten LA; van den Berg WB
J Immunol; 2003 Mar; 170(5):2655-62. PubMed ID: 12594294
[TBL] [Abstract][Full Text] [Related]
19. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D
BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296
[TBL] [Abstract][Full Text] [Related]
20. Acupotomy inhibits aberrant formation of subchondral bone through regulating osteoprotegerin/receptor activator of nuclear factor-κB ligand pathway in rabbits with knee osteoarthritis induced by modified Videman method.
Luxue Q; Changqing G; Ruili Z; Tong W; Junmei W; Yan G; Wei Z; Tingyao HU; Xilin C; Qian Z; Dian Z; Yue XU
J Tradit Chin Med; 2022 Jun; 42(3):389-399. PubMed ID: 35610008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
